• EP171584683 and EP171585037. Compounds for treating Synucleinopathies. Dalfó E (2017).
  • EP173825548. Inhibition of α-synuclein aggregation in Parkinson's disease. Dalfó E (2017).
  • EP171519093. Specialized pro-resolving lipid mediators for use in the treatment of neurodegenerative diseases and/or autoimmune diseases. López R (2017).
  • EP183824275. Circulating miRNAS as biomarkers for diagnosis of mild cognitive impairment and Alzheimer’s disease. Miñano A (2018).
  • EP183822568. Rapid detection of antibiotic resistance by bacterial ribosome immunoprecipitation. Quintana A, Sanz E (2018).
  • EP193820537. Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases. Puighermanal E, Quintana A, Sanz E (2019).
  • PCT/IL2019/050913. Vectors expressing klotho for treating cancer. Abraham C, Abraham M, Bosch A, Chillón M, Rubinek T, Wolf I (2019).